A workflow for the development of template-assisted membrane crystallization downstream processing for monoclonal...

Area of Science:

• Biotechnology and Bioprocessing
• Protein Crystallization
• Pharmaceutical Manufacturing

Background:

• Monoclonal antibodies (mAbs) are critical biopharmaceuticals produced in Chinese hamster ovary (CHO) cell lines.
• Traditional mAb purification relies on expensive, batch-mode Protein A chromatography with significant chemical and environmental costs.
• Protein A resin regeneration requires extensive chemical use, contributing to high operational expenses and environmental burden.

Purpose of the Study:

• To develop a systematic and flexible protocol for a robust, economic, and sustainable mAb purification platform.
• To replace the Protein A affinity chromatography stage in traditional purification processes.
• To enable gram-scale mAb production in a continuous flow system.

Main Methods:

• Utilized template-assisted membrane crystallization as a replacement for Protein A chromatography.
• Embedded crystallization templates within a membrane (e.g., polyvinylidene fluoride with polyvinyl alcohol).
• Investigated optimal crystallization conditions, template selection, and membrane choices for mAb separation.

Main Results:

• Demonstrated that a single crystallization step can replace conventional Protein A chromatography.
• Achieved gram-scale mAb production in continuous flow using the developed membrane crystallization process.
• Established a systematic approach for optimizing mAb crystallization parameters.

Conclusions:

• Template-assisted membrane crystallization presents a viable, sustainable, and cost-effective alternative to Protein A chromatography for mAb purification.
• The protocol facilitates the design of economic and environmentally friendly mAb purification platforms.
• This method offers a scalable solution for producing monoclonal antibodies.